文献速递烧伤创面修复

烧伤诊疗中的沙雷菌感染

Serratia Infections in Burn Care.
PubMed 文献 · J Burn Care Res · 2025-01-01

这项在美国烧伤协会认证烧伤中心开展的回顾性研究分析了2015至2020年22例粘质沙雷菌感染病例,患者平均烧伤总面积28%(范围2%-71%),68%烧伤面积超过20%TBSA,40.9%合并吸入性损伤;总体死亡率为23%,尽管及时给予抗生素治疗。早发型感染与死亡率升高相关,尤其在大面积烧伤患者中,7例中有5例死亡。

要点

  • 粘质沙雷菌多分离自烧伤创面组织(50%)和痰液(36%),平均培养阳性时间为8.7天。
  • 早发型感染与死亡率升高相关,大面积烧伤患者中7例有5例死亡。
  • 总体死亡率为23%,尽管及时给予抗生素治疗。

核心结论

  • 粘质沙雷菌感染与烧伤患者死亡率相关,早发型感染与死亡率升高相关,尤其在大面积烧伤患者中。
  • 靶向局部抗菌药物如Dakin溶液、纳米晶银和聚六亚甲基双胍可能有益,但缺乏最佳使用证据。
  • 需要更强的临床数据来指导局部抗菌药物的应用并改善结局。
  • 研究结果强调需要加强监测、优化治疗策略并开展粘质沙雷菌管理研究。

研究设计与样本

  • 回顾性研究,在美国烧伤协会认证烧伤中心开展,回顾了2015至2020年22例粘质沙雷菌感染病例。

主要发现

  • 患者平均烧伤总面积为28%(范围2%-71%),68%的患者烧伤面积超过20%TBSA,40.9%合并吸入性损伤。
  • 病原体最常分离自痰液(36%)和烧伤创面组织(50%),平均培养阳性时间为8.7天。
  • 早发型感染与死亡率升高相关,尤其在大面积烧伤患者中,7例中有5例死亡。
  • 总体死亡率为23%,尽管及时给予抗生素治疗。

关键数值与推荐

  • 靶向局部抗菌药物如Dakin溶液、纳米晶银和聚六亚甲基双胍可能有益,但缺乏最佳使用证据。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Serratia marcescens is an opportunistic nosocomial pathogen with significant implications for burn care due to its multidrug resistance, virulence, and ability to colonize hospital environments. This retrospective study, conducted at an American Burn Association Verified Burn Centre, reviewed 22 cases of S. marcescens infections from 2015 to 2020. Patients exhibited a mean total body surface area (TBSA) burned of 28% (range: 2%-71%), with 68% sustaining burns >20% TBSA and 40.9% presenting with inhalation injuries. The pathogen was most commonly isolated from sputum (36%) and burn wound tissue (50%), with a mean time to positive culture of 8.7 days. Early-onset infections were associated with increased mortality, particularly in patients with major burns, as five out of seven such individuals succumbed to infection. The overall mortality rate was 23%, despite timely antibiotic administration. Targeted topical antimicrobials, such as Dakin's solution, nanocrystalline silver, and polyhexamethylene biguanide, offer potential benefits but lack robust evidence for optimal use. Stronger clinical data are needed to guide their application and improve outcomes. These findings underscore the need for enhanced surveillance, refined treatment strategies, and research into S. marcescens management in burn care.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Wallace DL, Rogers AD. Serratia Infections in Burn Care. J Burn Care Res. 2025. PMID: 39801175. doi:10.1093/jbcr/iraf004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。